RxDoctor Payments Data

Jennifer Parish, MD

Dermatology · Philadelphia, PANPI 1164412144

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $43,600 of the $44,253 with a category attached, or 98.5%. Amgen accounts for 78.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $13,150 and has fallen 98.3% since, to $228 in 2025. Among dermatology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$44,253in general payments, 2019–2025

Across 57 payments — averaging $776.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$35K
  • Bristol Myers Squibb$9K
  • AbbVie$319
  • Johnson & Johnson$172
  • Sun Pharmaceutical Industries Inc.$72
  • Almirall LLC$50
  • plus $40 from 3 others
$1,051,834in research payments, 2019–2025

Across 295 payments — averaging $3565.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$376K
  • Pfizer$241K
  • Glenmark Pharmaceuticals Inc., USA$122K
  • Janssen Research & Development, LLC$83K
  • Incyte Corporation$63K
  • Ichnos Glenmark Innovation Inc$45K
  • plus $122K from 6 others

What the payments were for

  • Consulting fees$43,60099%
  • Food & beverage$4091%
  • Education$2441%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,253 in reported general payments places this provider in the 90th percentile of 626 dermatology providers in Pennsylvania.

See all dermatology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$93,842
Medicare patients
255
Services billed
1,238

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate51$1,765
Fluorouracil11$915
Ketoconazole48$895
Mometasone Furoate40$543
Minoxidil56$511
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc11$445
Betamethasone Dipropionate11$392
Hydrocortisone15$316
Spironolactone30$315
ValacyclovirValacyclovir Hcl11$290
Levocetirizine Dihydrochloride26$260
Mupirocin17$186
Hydroxyzine Hcl13$112
Triamcinolone Acetonide19$109
Prednisone13$45

Paid to pharmacies, not to this prescriber.

Other dermatology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →